{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:02:38Z","timestamp":1775577758863,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enhancer RNAs (eRNAs) are a subclass of non-coding RNAs that are generated during the transcription of enhancer regions and play an important role in tumourigenesis. In this study, we focused on the crucial eRNAs that participate in immune responses in invasive breast cancer (IBC). We first used The Cancer Genome Atlas and Human enhancer RNA Atlas to screen for tissue-specific eRNAs and their target genes. Through Pearson correlation analysis with immune genes, the eRNA WAKMAR2 was identified as a key candidate involved in IBC. Our further research suggested that WAKMAR2 is crucial in regulating the tumour microenvironment and may function by regulating immune-related genes, including IL27RA, RAC2, FABP7, IGLV1-51, IGHA1, and IGHD. Quantitative reverse transcription-polymerase chain reaction was used to detect the expression of WAKMAR2 in IBC and normal tissues, and the effect of WAKMAR2 on the regulation of downstream genes in MB-231 and MCF7 cells was studied in vitro. WAKMAR2 was found to be highly involved in tumour immunity and was downregulated in IBC tissues. Furthermore, the expression of WAKMAR2 and its target genes was observed at the pan-cancer level. This study provides evidence to suggest new potential targets for the treatment of breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-021-94784-3","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T10:02:58Z","timestamp":1627466578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Linbang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingkun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhou","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengxue","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"94784_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clin. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA: A Cancer J. Clin."},{"key":"94784_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41571-018-0089-9","volume":"16","author":"NF Pond\u00e9","year":"2019","unstructured":"Pond\u00e9, N. F., Zardavas, D. & Piccart, M. Progress in adjuvant systemic therapy for breast cancer. Nat. Rev. Clin. Oncol. 16, 27\u201344. https:\/\/doi.org\/10.1038\/s41571-018-0089-9 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"94784_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrclinonc.2011.122","volume":"8","author":"S Ogino","year":"2011","unstructured":"Ogino, S., Galon, J., Fuchs, C. S. & Dranoff, G. Cancer immunology\u2014Analysis of host and tumor factors for personalized medicine. Nat. Rev. Clin. Oncol. 8, 711\u2013719. https:\/\/doi.org\/10.1038\/nrclinonc.2011.122 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"94784_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","volume":"17","author":"N Pashayan","year":"2020","unstructured":"Pashayan, N. et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat. Rev. Clin. Oncol. 17, 687\u2013705. https:\/\/doi.org\/10.1038\/s41571-020-0388-9 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"94784_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker, A. B., Sudhan, D. R. & Arteaga, C. L. Overcoming endocrine resistance in breast cancer. Cancer Cell 37, 496\u2013513. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.009 (2020).","journal-title":"Cancer Cell"},{"key":"94784_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41571-020-0333-y","volume":"17","author":"A Byrne","year":"2020","unstructured":"Byrne, A. et al. Tissue-resident memory T cells in breast cancer control and immunotherapy responses. Nat. Rev. Clin. Oncol. 17, 341\u2013348. https:\/\/doi.org\/10.1038\/s41571-020-0333-y (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"94784_CR7","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.18632\/aging.102373","volume":"11","author":"F Bai","year":"2019","unstructured":"Bai, F. et al. Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment. Aging 11, 9328\u20139347. https:\/\/doi.org\/10.18632\/aging.102373 (2019).","journal-title":"Aging"},{"key":"94784_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12282-020-01048-5","volume":"27","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer. Breast Cancer (Tokyo, Japan) 27, 573\u2013585. https:\/\/doi.org\/10.1007\/s12282-020-01048-5 (2020).","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"94784_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrg3458","volume":"14","author":"LA Pennacchio","year":"2013","unstructured":"Pennacchio, L. A., Bickmore, W., Dean, A., Nobrega, M. A. & Bejerano, G. Enhancers: Five essential questions. Nat. Rev. Genet. 14, 288\u2013295. https:\/\/doi.org\/10.1038\/nrg3458 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"94784_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrg.2016.4","volume":"17","author":"W Li","year":"2016","unstructured":"Li, W., Notani, D. & Rosenfeld, M. G. Enhancers as non-coding RNA transcription units: Recent insights and future perspectives. Nat. Rev. Genet. 17, 207\u2013223. https:\/\/doi.org\/10.1038\/nrg.2016.4 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"94784_CR11","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1080\/15476286.2020.1712895","volume":"17","author":"JH Lee","year":"2020","unstructured":"Lee, J. H., Xiong, F. & Li, W. Enhancer RNAs in cancer: Regulation, mechanisms and therapeutic potential. RNA Biol. 17, 1550\u20131559. https:\/\/doi.org\/10.1080\/15476286.2020.1712895 (2020).","journal-title":"RNA Biol."},{"key":"94784_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2020.08.020","volume":"38","author":"H Chen","year":"2020","unstructured":"Chen, H. & Liang, H. A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancer. Cancer Cell 38, 701-715.e705. https:\/\/doi.org\/10.1016\/j.ccell.2020.08.020 (2020).","journal-title":"Cancer Cell"},{"key":"94784_CR13","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.7150\/thno.51931","volume":"11","author":"CW Pan","year":"2021","unstructured":"Pan, C. W. et al. Functional roles of antisense enhancer RNA for promoting prostate cancer progression. Theranostics 11, 1780\u20131794. https:\/\/doi.org\/10.7150\/thno.51931 (2021).","journal-title":"Theranostics"},{"key":"94784_CR14","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1038\/s41467-019-12543-5","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nat. Commun. 10, 4562. https:\/\/doi.org\/10.1038\/s41467-019-12543-5 (2019).","journal-title":"Nat. Commun."},{"key":"94784_CR15","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/s41388-018-0128-0","volume":"37","author":"W Jiao","year":"2018","unstructured":"Jiao, W. et al. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU\/p300\/EGR1\/HPSE axis. Oncogene 37, 2728\u20132745. https:\/\/doi.org\/10.1038\/s41388-018-0128-0 (2018).","journal-title":"Oncogene"},{"key":"94784_CR16","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/art.41396","volume":"72","author":"M van Hoolwerff","year":"2020","unstructured":"van Hoolwerff, M. et al. Elucidating epigenetic regulation by identifying functional cis-acting long noncoding RNAs and their targets in osteoarthritic articular cartilage. Arthritis Rheumatol. (Hoboken, N.J.) 72, 1845\u20131854. https:\/\/doi.org\/10.1002\/art.41396 (2020).","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"94784_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers, Z. R. et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 9, 34. https:\/\/doi.org\/10.1186\/s13073-017-0424-2 (2017).","journal-title":"Genome Med."},{"key":"94784_CR18","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Hopkins, A. & Jaffee, E. M. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl. J. Med. 377, 2500\u20132501. https:\/\/doi.org\/10.1056\/NEJMc1713444 (2017).","journal-title":"N. Engl. J. Med."},{"key":"94784_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature09033","volume":"465","author":"TK Kim","year":"2010","unstructured":"Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182\u2013187. https:\/\/doi.org\/10.1038\/nature09033 (2010).","journal-title":"Nature"},{"key":"94784_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.molcel.2018.06.008","volume":"71","author":"PF Tsai","year":"2018","unstructured":"Tsai, P. F. et al. A muscle-specific enhancer RNA mediates cohesin recruitment and regulates transcription in trans. Mol. Cell 71, 129-141.e128. https:\/\/doi.org\/10.1016\/j.molcel.2018.06.008 (2018).","journal-title":"Mol. Cell"},{"key":"94784_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-018-0010-y","volume":"18","author":"B Lim","year":"2018","unstructured":"Lim, B., Woodward, W. A., Wang, X., Reuben, J. M. & Ueno, N. T. Inflammatory breast cancer biology: The tumour microenvironment is key. Nat. Rev. Cancer 18, 485\u2013499. https:\/\/doi.org\/10.1038\/s41568-018-0010-y (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"94784_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jid.2018.11.033","volume":"139","author":"EK Herter","year":"2019","unstructured":"Herter, E. K. et al. WAKMAR2, a long noncoding RNA downregulated in human chronic wounds, modulates keratinocyte motility and production of inflammatory chemokines. J. Invest. Dermatol. 139, 1373\u20131384. https:\/\/doi.org\/10.1016\/j.jid.2018.11.033 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"94784_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","volume":"120","author":"P Berraondo","year":"2019","unstructured":"Berraondo, P. et al. Cytokines in clinical cancer immunotherapy. Br. J. Cancer 120, 6\u201315. https:\/\/doi.org\/10.1038\/s41416-018-0328-y (2019).","journal-title":"Br. J. Cancer"},{"key":"94784_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/imr.12435","volume":"272","author":"S Afridi","year":"2016","unstructured":"Afridi, S., Hoessli, D. C. & Hameed, M. W. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications. Immunol. Rev. 272, 151\u2013168. https:\/\/doi.org\/10.1111\/imr.12435 (2016).","journal-title":"Immunol. Rev."},{"key":"94784_CR25","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1158\/1078-0432.ccr-15-2052","volume":"22","author":"D Dibra","year":"2016","unstructured":"Dibra, D. et al. Lack of immunomodulatory interleukin-27 enhances oncogenic properties of mutant p53 in vivo. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 22, 3876\u20133883. https:\/\/doi.org\/10.1158\/1078-0432.ccr-15-2052 (2016).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"94784_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ijbiomac.2019.07.016","volume":"137","author":"P Xia","year":"2019","unstructured":"Xia, P. et al. Down-regulation of RAC2 by small interfering RNA restrains the progression of osteosarcoma by suppressing the Wnt signaling pathway. Int. J. Biol. Macromol. 137, 1221\u20131231. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.07.016 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"94784_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030766","author":"WN Goldsberry","year":"2020","unstructured":"Goldsberry, W. N. et al. Inhibiting WNT ligand production for improved immune recognition in the ovarian tumor microenvironment. Cancers https:\/\/doi.org\/10.3390\/cancers12030766 (2020).","journal-title":"Cancers"},{"key":"94784_CR28","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/s41388-019-0893-4","volume":"38","author":"A Cordero","year":"2019","unstructured":"Cordero, A. et al. FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis. Oncogene 38, 6445\u20136460. https:\/\/doi.org\/10.1038\/s41388-019-0893-4 (2019).","journal-title":"Oncogene"},{"key":"94784_CR29","doi-asserted-by":"publisher","first-page":"e0193799","DOI":"10.1371\/journal.pone.0193799","volume":"13","author":"E Miyauchi","year":"2018","unstructured":"Miyauchi, E. et al. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PLoS ONE 13, e0193799. https:\/\/doi.org\/10.1371\/journal.pone.0193799 (2018).","journal-title":"PLoS ONE"},{"key":"94784_CR30","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1038\/s41598-019-40826-w","volume":"9","author":"HM Hsu","year":"2019","unstructured":"Hsu, H. M. et al. Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. Sci. Rep. 9, 4484. https:\/\/doi.org\/10.1038\/s41598-019-40826-w (2019).","journal-title":"Sci. Rep."},{"key":"94784_CR31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","volume":"179","author":"DP Hollern","year":"2019","unstructured":"Hollern, D. P. et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179, 1191-1206.e1121. https:\/\/doi.org\/10.1016\/j.cell.2019.10.028 (2019).","journal-title":"Cell"},{"key":"94784_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaoncol.2018.4942","volume":"5","author":"R Cohen","year":"2019","unstructured":"Cohen, R. et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status. JAMA Oncol. 5, 551\u2013555. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4942 (2019).","journal-title":"JAMA Oncol."},{"key":"94784_CR33","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41379-020-0589-x","volume":"33","author":"X Sun","year":"2020","unstructured":"Sun, X. et al. Invasive apocrine carcinoma of the breast: Clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas. Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc 33, 2473\u20132482. https:\/\/doi.org\/10.1038\/s41379-020-0589-x (2020).","journal-title":"Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc"},{"key":"94784_CR34","doi-asserted-by":"publisher","first-page":"23306","DOI":"10.18632\/aging.104115","volume":"12","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer. Aging 12, 23306\u201323325. https:\/\/doi.org\/10.18632\/aging.104115 (2020).","journal-title":"Aging"},{"key":"94784_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1078-0432.ccr-15-1678","volume":"22","author":"JC Dudley","year":"2016","unstructured":"Dudley, J. C., Lin, M. T., Le, D. T. & Eshleman, J. R. Microsatellite instability as a biomarker for PD-1 blockade. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 22, 813\u2013820. https:\/\/doi.org\/10.1158\/1078-0432.ccr-15-1678 (2016).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"94784_CR36","doi-asserted-by":"publisher","first-page":"D932","DOI":"10.1093\/nar\/gkaa940","volume":"49","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. HeRA: An atlas of enhancer RNAs across human tissues. Nucl. Acids Res. 49, D932-d938. https:\/\/doi.org\/10.1093\/nar\/gkaa940 (2021).","journal-title":"Nucl. Acids Res."},{"key":"94784_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","volume":"37","author":"Y He","year":"2018","unstructured":"He, Y., Jiang, Z., Chen, C. & Wang, X. Classification of triple-negative breast cancers based on immunogenomic profiling. J. Exp. Clin. Cancer Res.: CR 37, 327. https:\/\/doi.org\/10.1186\/s13046-018-1002-1 (2018).","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"94784_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/nar\/30.1.42","volume":"30","author":"M Kanehisa","year":"2002","unstructured":"Kanehisa, M., Goto, S., Kawashima, S. & Nakaya, A. The KEGG databases at GenomeNet. Nucl. Acids Res. 30, 42\u201346. https:\/\/doi.org\/10.1093\/nar\/30.1.42 (2002).","journal-title":"Nucl. Acids Res."},{"key":"94784_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/jad-2012-120886","volume":"31","author":"Y Zeng","year":"2012","unstructured":"Zeng, Y., Liu, Y., Wu, M., Liu, J. & Hu, Q. Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging. J. Alzheimer\u2019s Dis.: JAD 31, 765\u2013778. https:\/\/doi.org\/10.3233\/jad-2012-120886 (2012).","journal-title":"J. Alzheimer's Dis.: JAD"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94784-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:46:09Z","timestamp":1670067969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94784-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94784"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94784-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15328"}}